Hereditary elliptocytosis

What it is

From: Orphanet

Hereditary elliptocytosis (HE) is a rare clinically and genetically heterogeneous disorder of the red cell membrane characterized by manifestations ranging from mild to severe transfusion-dependent hemolytic anemia but with the majority of patients being asymptomatic.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal erythrocyte morphology · Obligate (100%)

Any structural abnormality of erythrocytes (red-blood cells).

Elliptocytosis · Frequent (79-30%)

The presence of elliptical, cigar-shaped erythrocytes on peripheral blood smear.

Increased red cell osmotic fragility · Frequent (79-30%)

Congenital hemolytic anemia · Occasional (29-5%)

A form of hemolytic anemia with congenital onset.

Exercise intolerance · Occasional (29-5%)

A functional motor deficit where individuals whose responses to the challenges of exercise fail to achieve levels considered normal for their age and gender.

Fatigue · Occasional (29-5%)

A subjective feeling of tiredness characterized by a lack of energy and motivation.

Hemolytic anemia · Occasional (29-5%)

A type of anemia caused by premature destruction of red blood cells (hemolysis).

Hyperbilirubinemia · Occasional (29-5%)

An increased amount of bilirubin in the blood.

Jaundice · Occasional (29-5%)

Yellow pigmentation of the skin due to bilirubin, which in turn is the result of increased bilirubin concentration in the bloodstream.

Neonatal hyperbilirubinemia · Occasional (29-5%)

A type of hyperbilirubinemia with neonatal onset.

Poikilocytosis · Occasional (29-5%)

The presence of abnormally shaped erythrocytes.

Prolonged neonatal jaundice · Occasional (29-5%)

Neonatal jaundice refers to a yellowing of the skin and other tissues of a newborn infant as a result of increased concentrations of bilirubin in the blood. Neonatal jaundice affects over half of all newborns to some extent in the first week of life. Prolonged neonatal jaundice is said to be present if the jaundice persists for longer than 14 days in term infants and 21 days in preterm infants.

Reticulocytosis · Occasional (29-5%)

An elevation in the number of reticulocytes (immature erythrocytes) in the peripheral blood circulation.

Skin ulcer · Occasional (29-5%)

A discontinuity of the skin exhibiting complete loss of the epidermis and often portions of the dermis and even subcutaneous fat.

Other findings in the same source

From: Orphanet

Additional reported features include Splenomegaly (Occasional (29-5%)); Stomatocytosis (Occasional (29-5%)); Abdominal pain (Very rare (<4-1%)); Chills (Very rare (<4-1%)); Cholelithiasis (Very rare (<4-1%)); Fever (Very rare (<4-1%)); Frontal bossing (Very rare (<4-1%)); Hydrops fetalis (Very rare (<4-1%)); Postnatal growth retardation (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

All ages

Inheritance in the source

From: Orphanet

Autosomal dominant; Autosomal recessive

Frequency and the population described

From: Orphanet

Point prevalence: 1-5 / 10 000; Worldwide; Class only.

Which doctor should you see?

The suggested department for discussing Hereditary elliptocytosis is Haematology, with a haematologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which blood-cell, marrow, bleeding or clotting finding matters most?
• Does the diagnosis need confirmation or a more precise subtype?
• Which symptoms or laboratory changes should trigger earlier review?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Hereditary elliptocytosis. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.